100 results about "Cesarean delivery" patented technology

Devices, systems and methods for occluding blood vessels include a deployable constrictor having opposed pressure-applying portions, a delivery shaft configured to intravaginally advance the constrictor to the patient's cervix, a location sensor configured to detect a blood vessel, a deployment member for deploying the constrictor about the patient's cervix, and optionally a guide. The constrictor has a first configuration to receive a cervix and a second configuration to apply pressure to the cervical area to occlude a uterine artery by compression from the pressure-applying members. The pressure-applying members may be released from the cervix after a limited therapeutically effective time. The invention finds use in, for example, treating uterine disorders and conditions which may be treated by occlusion of the uterine arteries, such as uterine fibroids, dysfunctional uterine bleeding, post-partum hemorrhage, and bleeding associated with caesarian sections.

The present invention provides the use of a composition comprising uronic acid oligosaccharide for the manufacture of a composition for enteral administration to an infant delivered via caesarean section.

The present invention is related to piperazine-2-carboxamide derivatives of formula (I) for the treatment and / or prophylaxis of preterm labor, premature birth, dysmenorrhea and for stopping labor prior to cesarean delivery. Wherein A, X, Y, R1 and R2 are as defined in the description.

The invention discloses a whole birth process abdominal pressure delivery assisting instrument, comprising a main control device, and an abdominal pressure zone device, an external operating device, an air charging power-off protecting device and a pressure sensing device, which are electrically connected with the main control device, wherein the abdominal pressure zone device comprises an abdominal pressure zone airbag device and an abdominal pressure zone vibration device, the abdominal pressure zone airbag device is used for increasing the abdominal pressure in the birth process, and the abdominal pressure zone vibration device is used for preventing and reducing postpartum hemorrhage; the external operating device is used for inputting control commands for controlling the working condition of the abdominal pressure zone device state and the working condition of the abdominal pressure zone vibration device; and the air charging power-off protecting device is used for ending air charging operation when a pressure value signal exceeds a preset value. By virtue of the whole birth process abdominal pressure deliver assisting instrument disclosed by the invention, a user can control the abdominal pressure zone device by virtue of the external operating device, so that not only can natural childbirth be safely and effectively assisted by virtue of the abdominal pressure airbag device to shorten the birth process, but also the postpartum hemorrhage can be prevented and reduced by virtue of the abdominal pressure zone vibration device to relieve childbirth pains of a lying-in woman, promote natural childbirth so as to reduce the rate of cesarean delivery and improve the quality of the obstetrical department.

The present invention is related to thiazolidine carboxamide derivatives of formula (II) for the treatment and / or prophylaxis of preterm labor, premature birth, dysmenorrhea and for stopping labor prior to cesarean delivery.

A fenestration drape and a method for providing skin-to-skin contact of a newborn with the mother immediately after birth during a Cesarean delivery are provided. The fenestration drape includes a portal which may be opened and reclosed without compromise to the sterile barrier. The method facilitates the critical contact without interruption and with continuity of sterile field throughout the procedure.

The invention provides a method for separating an active ingredient, with an anti-oxidation effect, from human umbilical cord mesenchymal stem cell culture fluid. The active ingredient is prepared according to the following steps: in a process of normal cesarean delivery operation or eutocia, taking an umbilical cord under an aseptic condition, cleaning and disinfecting the umbilical cord, then removing blood vessels and mucosae, cutting umbilical cord tissues into pieces, and putting into a culture bottle for culture; taking the culture fluid of human umbilical cord mesenchymal stem cells growing in a log phase, and performing centrifugal ultrafiltration by adopting ultrafiltration centrifuge tubes with different specifications, thus finally obtaining an outlier having the anti-oxidationeffect and the molecular weight of 10 to 30Kda. The outlier can be freeze-dried into freeze-dried powder, thus facilitating storage and use. The human umbilical cord mesenchymal stem cell culture fluid outlier provided by the invention has good anti-oxidation activity, can help cells resist damage of free radicals; the outlier is from a human body tissue, is high in safety, and is expected to be applied to products such as drugs, health care products, skin care products and other daily chemicals. The separation method provided by the invention is simple and easy, and is low-cost, free of environment pollution and suitable for industrialized production.

The invention relates to methods and compositions for restoring normal microbiota in pre-term newborns or newborns delivered by Cesarean section and methods for preventing or ameliorating diseases associated with delivery by Cesarean section or pre-term birth comprising administering to said newborns at the time of birth or shortly thereafter an effective amount of a vaginal microbiota inoculum obtained from the newborn's mother or a donor or an effective amount of a probiotic composition. The invention also relates to a device for collecting maternal vaginal microbiota from the vaginal canal of a patient. The device can have a housing forming a cavity, an absorbent material removable disposed within the cavity, and a deployment element disposed in the housing and movable along a length of the housing. The movement of the deployment element can displace the absorbent material out of the cavity and in to the vaginal canal.